Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	[1]
Revenues
Net earned premiums	$ 2,248	$ 2,059
Net investment income	525	448
Net investment losses	(35)	(11)
Non-insurance warranty revenue	407	382
Other revenues	7	7
Total revenues	3,152	2,885
Claims, Benefits and Expenses
Insurance claims and policyholders’ benefits (re-measurement gain (loss) of $1 and $5)	1,653	1,478
Amortization of deferred acquisition costs	379	344
Non-insurance warranty expense	384	354
Other operating expenses	337	326
Interest	28	28
Total claims, benefits and expenses	2,781	2,530
Income before income tax	371	355
Income tax expense	(74)	(60)
Net income	$ 297	$ 295	[2]
Basic earnings per share
Basic earnings per share (in usd per share)	$ 1.10	$ 1.08
Diluted earnings per share
Diluted earnings per share (in usd per share)	$ 1.09	$ 1.08
Weighted Average Outstanding Common Stock and Common Stock Equivalents
Weighted average shares outstanding (in shares)	271.3	271.8
Diluted (in shares)	272.3	272.9

[1] As of January 1, 2023, the Company adopted ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2018-12) using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been adjusted to reflect application of the new guidance. See Note A to the Condensed Consolidated Financial Statements for additional information.

[2] As of January 1, 2023, the Company adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been adjusted to reflect application of the new guidance. See Note A to the Condensed Consolidated Financial Statements for additional information.